Related Experiment Video
Updated: Dec 18, 2025
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
COVID-19 IN DIABETES PATIENTS IN UKRAINE: LESSONS FOR DOCTORS AND PATIENTS
1Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.
Insights
The COVID-19 pandemic in Ukraine shows younger patients and more women affected than in other countries. Diabetes and cardiovascular diseases significantly increase mortality risk, especially in those over 50.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- The World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020.
- Ukraine reported its first COVID-19 case on March 3, 2020, and its first death on March 13, 2020.
- As of April 22, 2020, Ukraine had 6592 cases, with 174 deaths (2.64% lethality) and 467 recoveries (7.08%).
Purpose of the Study:
- To analyze the epidemiology of COVID-19 in Ukraine.
- To investigate the negative influence of diabetes mellitus on COVID-19 progression.
- To provide recommendations for prophylaxis and treatment of co-morbid COVID-19 and diabetes mellitus patients.
Main Methods:
- Descriptive epidemiological analysis of COVID-19 cases and deaths in Ukraine.
- Review of global and Ukrainian data on COVID-19 and diabetes mellitus co-morbidity.
- Analysis of risk factors, including age, sex, and co-existing conditions.
Main Results:
- COVID-19 patients in Ukraine are notably younger (predominantly 30-59 years old) compared to China and other European countries.
- Women (56.0%) were more frequently infected than men (44.0%), though male deaths (51.7%) slightly outnumbered female deaths (48.3%).
- High mortality rates were observed in patients over 50 (85% of deaths), with severe co-morbidities like cardiovascular diseases (74%), diabetes mellitus (22%), and others significantly present in deceased patients.
Conclusions:
- COVID-19 epidemiology in Ukraine presents unique demographic features, including a younger affected population and higher female infection rates.
- The presence of co-morbidities, particularly cardiovascular diseases and diabetes mellitus, is a critical factor in COVID-19 lethality.
- Urgent recommendations for managing and treating patients with co-existing diabetes mellitus and COVID-19 are essential.
Abstract:
World Health Organization recognized coronavirus disease 2019 (COVID-19) as a pandemic on 11 March 2020. The first case of COVID-19 in Ukraine was confirmed on 3 March 2020 in Chernivtsi and the first lethal case was reported on 13 March 2020. As of 22 April 2020 6592 cases of COVID-19 have been reported in Ukraine, among these cases 174 caused death (2.64% lethality), 467 patients (7.08% of cases) have recovered. The feature of COVID-19 pandemics in Ukraine is that the age of patients is lower (50-59 years old, 40-49 years old and 30-39 years old) than in China and other European countries. Another feature of COVID-19 epidemiology in Ukraine is that virus cause disease in women (56.0%) more often than in men (44.0%). But there are more male patients in other countries. Although there are more male deaths (51.7%) than female (48.3%) in Ukraine. Deaths have occurred in 30-49 years old patients (14%), in 50-69 years old patients (48%), in 70 years old and older patients (38%). 85% of all deaths were over 50 years of age. 79% of patients who died from COVID-19 had severe cardiovascular diseases, diabetes mellitus, neoplasms, renal diseases, respiratory disorders and obesity. In total, co-morbidities (one or several) have been cardiovascular diseases (74%), diabetes mellitus (22%), lungs diseases (9%), neoplasms (8%), renal diseases (7%). In this article we analyzed epidemiology and causes of negative influence of diabetes mellitus on COVID-19 progress in world and Ukraine. We also made recommendations on prophylaxis and patients treatment in cases of COVID-19 and diabetes mellitus co-morbidity.
More Related Videos
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...